Femoral arterial murmurs
Specialty: Cardiovascular.
Why it occurs
- Atherosclerotic stenosis of the common or superficial femoral artery
- External iliac artery stenosis with turbulent flow propagation
- Femoral arteriovenous fistula after cardiac or traumatic catheterization
- Pseudoaneurysm of the femoral artery
- Extrinsic compression of the femoral artery due to inguinal masses
Initial workup
Duplex Doppler ultrasound of the femoral artery and the arterial system of the lower extremities to quantify stenosis, characterize arterial flow (high systolic velocity peaks) and rule out pseudoaneurysms or fistulated communications; Bilateral Ankle-Arm Index (ABI) to assess the severity of global peripheral ischemia; Computed tomography angiography (CT-Angio) of the lower limbs if surgical or endovascular revascularization intervention is planned.
red flags
Presence of a systolic or continuous murmur in the inguinal region or middle third of the thigh, associated with ischemic pain at rest of the ipsilateral lower limb, clear skin coldness, paleness when raising the leg, loss of distal pulses (pedius, tibialis posterior), presence of a pulsating and painful inguinal mass (suggestive of pseudoaneurysm or large-caliber fistula post-puncture), or motor weakness of the foot. Indicates severe obstructive arterial vasculopathy or major vascular complication after endovascular procedure, requiring evaluation by vascular surgery.
Standard management
- Clopidogrel — antiplatelet agent indicated if there is intolerance to aspirin or after placement of a vascular stent in the femoral artery; 75 mg per day orally
- Acetylsalicylic acid — first-line antiplatelet for the prevention of cardiovascular ischemic events in peripheral arterial disease; 100 mg once a day orally
- Atorvastatin — statin for lipid control, reduction of systemic vascular risk and endothelial stabilization of the femoral plate; 40 to 80 mg once daily orally
- Cilostazol (indicated if the murmur is associated with limiting intermittent claudication without heart failure; 100 mg every 12 hours orally).
Educational guidance for study. It is NOT a prescription recommendation. The actual choice depends on the cause, the patient, and current guidelines.
- Area
- Cardiovascular
- Listed causes
- 5
- Treatment options
- 4